학술논문

Early Release - Heterogeneity of Dengue Illness in Community-Based Prospective Study, Iquitos, Peru - Volume 26, Number 9—September 2020 - Emerging Infectious Diseases journal - CDC
Document Type
article
Source
Emerging Infectious Diseases. 26(9)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Infectious Diseases
Vaccine Related
Prevention
Vector-Borne Diseases
Biodefense
Emerging Infectious Diseases
Rare Diseases
Infection
Good Health and Well Being
Dengue
Dengue Virus
Humans
Peru
Prospective Studies
Surveys and Questionnaires
Iquitos
cohort studies
community-based prospective study
dengue
dengue virus
epidemiology
heterogeneity
humans
viruses
Medical Microbiology
Public Health and Health Services
Microbiology
Clinical sciences
Epidemiology
Health services and systems
Language
Abstract
Measuring heterogeneity of dengue illness is necessary to define suitable endpoints in dengue vaccine and therapeutic trials and will help clarify behavioral responses to illness. To quantify heterogeneity in dengue illness, including milder cases, we developed the Dengue Illness Perceptions Response (IPR) survey, which captured detailed symptom data, including intensity, duration, and character, and change in routine activities caused by illness. During 2016-2019, we collected IPR data daily during the acute phase of illness for 79 persons with a positive reverse transcription PCR result for dengue virus RNA. Most participants had mild ambulatory disease. However, we measured substantial heterogeneity in illness experience, symptom duration, and maximum reported intensity of individual symptoms. Symptom intensity was a more valuable predicter of major activity change during dengue illness than symptom presence or absence alone. These data suggest that the IPR measures clinically useful heterogeneity in dengue illness experience and its relation to altered human behavior.